P2RX7 and primary cutaneous T-cell non-Hodgkin lymphoma: Our observations in HH cells led us to hypothesize that, similar to other types of hematological and non-hematological cancers [38,39], at least some CTCL tumors may use eATP to activate purinergic receptor calcium signaling and stimulate their own growth and proliferation.